{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T09:40:07Z","timestamp":1743932407763,"version":"3.40.3"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1007\/s00011-012-0537-4","type":"journal-article","created":{"date-parts":[[2012,7,31]],"date-time":"2012-07-31T04:36:49Z","timestamp":1343709409000},"page":"1363-1367","source":"Crossref","is-referenced-by-count":3,"title":["The effect of clodronate on a mevalonate kinase deficiency cellular model"],"prefix":"10.1007","volume":"61","author":[{"given":"Valentina","family":"Zanin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annalisa","family":"Marcuzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Piscianz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josef","family":"Vuch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Monica","family":"Bianco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Monasta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuliana","family":"Decorti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Crovella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,8,1]]},"reference":[{"key":"537_CR1","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1182\/blood-2008-03-144667","volume":"112","author":"LM Kuijk","year":"2008","unstructured":"Kuijk LM, Beekman JM, Koster J, et al. HMG-CoA reductase inhibition induces IL-1beta release through Rac1\/PI3\u00a0K\/PKB-dependent caspase-1 activation. Blood. 2008;112:3563\u201373.","journal-title":"Blood"},{"key":"537_CR2","doi-asserted-by":"crossref","first-page":"3690","DOI":"10.1002\/art.22194","volume":"54","author":"SH Mandey","year":"2006","unstructured":"Mandey SH, Kuijk LM, Frenkel J, et al. A role for geranylgeranylation in interleukin-1beta secretion. Arthritis Rheum. 2006;54:3690\u20135.","journal-title":"Arthritis Rheum"},{"key":"537_CR3","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1203\/PDR.0b013e3181761870","volume":"64","author":"A Marcuzzi","year":"2008","unstructured":"Marcuzzi A, Pontillo A, De Leo L, et al. Natural isoprenoids are able to reduce inflammation in a mouse model of mevalonate kinase deficiency. Pediatr Res. 2008;64:177\u201382.","journal-title":"Pediatr Res"},{"key":"537_CR4","first-page":"260","volume":"63","author":"EJ Bodar","year":"2005","unstructured":"Bodar EJ, van der Hilst JC, Drenth JP, et al. Effect of etanercept and anakinra on inflammatory attacks in the hyper-IgD syndrome: introducing a vaccination provocation model. Neth J Med. 2005;63:260\u20134.","journal-title":"Neth J Med"},{"key":"537_CR5","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1007\/s10495-011-0621-1","volume":"16","author":"A Marcuzzi","year":"2011","unstructured":"Marcuzzi A, Piscianz E, Girardelli M, et al. Defect in mevalonate pathway induces pyroptosis in Raw 264.7 murine monocytes. Apoptosis. 2011;16:882\u20138.","journal-title":"Apoptosis"},{"key":"537_CR6","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.intimp.2010.03.008","volume":"10","author":"A Marcuzzi","year":"2010","unstructured":"Marcuzzi A, Tommasini A, Crovella S, et al. Natural isoprenoids inhibit LPS induced-production of cytokines and nitric oxide in aminobisphosphonate-treated monocytes. Int Immunopharmacol. 2010;10:639\u201342.","journal-title":"Int Immunopharmacol"},{"key":"537_CR7","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s10545-006-0408-7","volume":"29","author":"M Cailliez","year":"2006","unstructured":"Cailliez M, Garaix F, Rousset-Rouviere C, et al. Anakinra is safe and effective in controlling hyperimmunoglobulinaemia D syndrome-associated febrile crisis. J Inherit Metab Dis. 2006;29:763.","journal-title":"J Inherit Metab Dis"},{"key":"537_CR8","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/MD.0b013e318190cfb7","volume":"87","author":"JC Hilst van der","year":"2008","unstructured":"van der Hilst JC, Bodar EJ, Barron KS, et al. Long-term follow-up, clinical features and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome. Medicine. 2008;87:301\u201310.","journal-title":"Medicine."},{"key":"537_CR9","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.toxlet.2010.08.013","volume":"199","author":"Y Shikama","year":"2010","unstructured":"Shikama Y, Nagai Y, Okada S, et al. Pro-IL-1beta accumulation in macrophages by alendronate and its prevention by clodronate. Toxicol Lett. 2010;199:123\u20138.","journal-title":"Toxicol Lett"},{"key":"537_CR10","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.phrs.2010.02.012","volume":"61","author":"L Leo De","year":"2010","unstructured":"De Leo L, Marcuzzi A, Decorti G, et al. Targeting farnesyl-transferase as a novel therapeutic strategy for mevalonate kinase deficiency: in vitro and in vivo approaches. Pharmacol Res. 2010;61:506\u201310.","journal-title":"Pharmacol Res"},{"key":"537_CR11","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0928-0987(98)00065-7","volume":"8","author":"N Makkonen","year":"1999","unstructured":"Makkonen N, Salminen A, Rogers MJ, et al. Contrasting effects of alendronate and clodronate on RAW 264 macrophages: the role of a bisphosphonate metabolite. Eur J Pharm Sci. 1999;8:109\u201318.","journal-title":"Eur J Pharm Sci"},{"key":"537_CR12","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1359\/jbmr.2003.18.2.204","volume":"18","author":"JC Frith","year":"2003","unstructured":"Frith JC, Rogers MJ. Antagonist effects of different classes of bisphosphonates in osteoclasts and macrophages in vitro. J Bone Miner Res. 2003;18:204\u201312.","journal-title":"J Bone Miner Res"},{"key":"537_CR13","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.bcp.2006.09.031","volume":"73","author":"MF Moreau","year":"2007","unstructured":"Moreau MF, Guillet C, Massin P, et al. Comparative effects of five bisphosphonates on apoptosis of macrophage cells in vitro. Biochem Pharmacol. 2007;73:718\u201323.","journal-title":"Biochem Pharmacol"},{"key":"537_CR14","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S0022-3565(25)12897-8","volume":"277","author":"N Makkonen","year":"1996","unstructured":"Makkonen N, Hirvonen MR, Teravainen T, et al. Different effects of three bisphosphonates on nitric oxide production by Raw 264 macrophages-like cells in vitro. J Pharmacol Exp Ther. 1996;277:1097\u2013102.","journal-title":"J Pharmacol Exp Ther"},{"key":"537_CR15","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.bone.2011.04.022","volume":"49","author":"RG Russell","year":"2011","unstructured":"Russell RG. Bisphosphonates: the first 40\u00a0years. Bone. 2011;49:2\u201319.","journal-title":"Bone"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-012-0537-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00011-012-0537-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-012-0537-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T09:10:30Z","timestamp":1743930630000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00011-012-0537-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,1]]},"references-count":15,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["537"],"URL":"https:\/\/doi.org\/10.1007\/s00011-012-0537-4","relation":{},"ISSN":["1023-3830","1420-908X"],"issn-type":[{"type":"print","value":"1023-3830"},{"type":"electronic","value":"1420-908X"}],"subject":[],"published":{"date-parts":[[2012,8,1]]}}}